Yiting Lin

Yiting Lin

Auto-generated profile, based on publicly available information

Yiting Lin

Fourth Military Medical University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JCJiaoling Chen
Jiaoling Chen
ZZZhenlai Zhu
Zhenlai Zhu
QLQingyang Li
Qingyang Li
YLYiting Lin
Yiting Lin
EDErle Dang
Erle Dang
SSShuai Shao
Shuai Shao

1 June 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ZZZhenlai Zhu
Zhenlai Zhu
JCJiaoling Chen
Jiaoling Chen
YLYiting Lin
Yiting Lin
CZChen Zhang
Chen Zhang
WLWei Li
Wei Li
GWGang Wang
Gang Wang

1 August 2022 in Seminars in Cell & Developmental Biology
Verified
Journal Article
Closed access
YLYiting Lin
Yiting Lin
WZWeigang Zhang
Weigang Zhang
BLBing Li
Bing Li
GWGang Wang
Gang Wang

1 November 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
YLYiting Lin
Yiting Lin
KXKe Xue
Ke Xue
QLQingyang Li
Qingyang Li
ZLZhenhua Liu
Zhenhua Liu
ZZZhenlai Zhu
Zhenlai Zhu
BLBing Li
Bing Li

23 September 2023 in Experimental Dermatology
Verified
Journal Article
Closed access
ZLZhenhua Liu
Zhenhua Liu
XWXinyu Wang
Xinyu Wang
YMYao Ma
Yao Ma
YLYiting Lin
Yiting Lin
GWGang Wang
Gang Wang

1 January 2019 in Medicine
Verified
Journal Article
Open access
YNYujie Niu
Yujie Niu
YLYiting Lin
Yiting Lin
HPHailin Pang
Hailin Pang
WSWeiwei Shen
Weiwei Shen
LLLili Liu
Lili Liu
HZHelong Zhang
Helong Zhang
Bone metastases (BM) are prevalent among lung cancer (LC) patients. Although some studies revealed associated factors for BM, each of these papers focused on a few factors. Few studies have identified the potential risk factors through a systematic review. We searched through PubMed, MEDLINE, Web of Science, EMBASE, Cochrane Library and Cochrane Central Register of Controlled Trials for literature from January 1990 to November 2017. The types of literature included case–control studies, cohort studies, randomized controlled trials and systematic reviews. From included 12 studies, we identified that lower blood calcium, T4 stage, N3 stage, P-stage III, nonsquamous, bone sialoprotein expression, elevated carcino-embryonic antigen levels were risk factors for bone metastasis in lung cancer patients. We identified that T4 stage, N3 stage, and positive bone sialoprotein expression associated with an increased risk of bone metastasis. Further studies are needed to assess these relationships and to establish the risk prediction model of bone metastasis.